🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s WGRX Holdings & Trades

First Buy
Q4 2025
Duration Held
2 Quarters
Largest Add
Q4 2025
+292 Shares
Current Position
546 Shares
$2,634 Value

Steven Cohen's WGRX Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 546 shares of Wellgistics Health, Inc. (WGRX) worth $2,634, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Steven Cohen has initiated a new position in WGRX, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 254 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Wellgistics Health (WGRX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Wellgistics Health (WGRX) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +254 Add 86.99% 546 $4.82
Q4 2025 +292 New Buy 292 $20.01

Steven Cohen's Wellgistics Health Investment FAQs

Steven Cohen first purchased Wellgistics Health, Inc. (WGRX) in Q4 2025, acquiring 292 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Wellgistics Health, Inc. (WGRX) for 2 quarters since Q4 2025.

Steven Cohen's largest addition to Wellgistics Health, Inc. (WGRX) was in Q4 2025, adding 292 shares worth $5,842.

According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 546 shares of Wellgistics Health, Inc. (WGRX), valued at approximately $2,634.

As of the Q1 2026 filing, Wellgistics Health, Inc. (WGRX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Wellgistics Health, Inc. (WGRX) was 546 shares, as reported at the end of Q1 2026.